Exosens SAS

Exosens: Availability of documents and information relating to the Combined General Meeting of 23 May 2025

30 Apr 2025 12:00:00 By Nasdaq GlobeNewswire

Exosens: Availability of 2024 Universal Registration Document

30 Apr 2025 11:45:00 By Nasdaq GlobeNewswire

Exosens delivers strong revenue growth in Q1 2025 in a dynamic defense market environment; Fully on track to 2025 guidance

28 Apr 2025 01:30:00 By Nasdaq GlobeNewswire

EXOSENS JOINS THE SBF 120 INDEX

20 Mar 2025 02:30:00 By Nasdaq GlobeNewswire

Exosens makes first US investment in night vision production capacity to address growing demand and benefit from new opportunities

03 Mar 2025 01:31:00 By Nasdaq GlobeNewswire

Exosens delivers very strong full-year 2024 results, overperforming on its IPO guidance; Sustained growth dynamic anticipated for 2025-2026

03 Mar 2025 01:30:00 By Nasdaq GlobeNewswire

Exosens strengthens its position as a key supplier to Senop for night vision image intensifier tubes highlighting increasing demand for night vision goggles

24 Feb 2025 01:30:00 By Nasdaq GlobeNewswire

Half-yearly report on Exosens' liquidity contract with Kepler Cheuvreux

14 Jan 2025 12:00:00 By Nasdaq GlobeNewswire

Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth

08 Jan 2025 01:30:00 By Nasdaq GlobeNewswire

German parliament approves the 3rd option of the OCCAR night vision contract under which 25 000 binoculars will be provided equipped with Photonis image intensifier tubes

18 Dec 2024 12:06:56 By Nasdaq GlobeNewswire

Exosens joins the MSCI France Small Cap index

25 Nov 2024 12:00:00 By Nasdaq GlobeNewswire

Exosens: Continued strong growth momentum and significantly improved adjusted gross margin in 9M 2024

28 Oct 2024 02:30:00 By Nasdaq GlobeNewswire

Exosens announces agreement to acquire NVLS (Night Vision Laser Spain), specialist in night vision equipment

22 Oct 2024 01:30:00 By Nasdaq GlobeNewswire

EXOSENS AND THEON INTERNATIONAL FRAME THEIR LONG-TERM COMMERCIAL RELATIONSHIP TO COVER NIGHT VISION DEVICES BUSINESS

10 Sep 2024 13:30:00 By Nasdaq GlobeNewswire

Exosens - H1 2024 Results

03 Sep 2024 01:00:00 By Nasdaq GlobeNewswire

EXOSENS COMPLETES THE ACQUISITION OF LR TECH, LEADER IN SPECTRORADIOMETER BASED SOLUTIONS

02 Sep 2024 12:06:59 By Nasdaq GlobeNewswire

EXOSENS COMPLETES THE CLOSING OF THE ACQUISITION OF CENTRONIC, LEADER IN RADIATION DETECTION SOLUTIONS

01 Aug 2024 02:00:00 By Nasdaq GlobeNewswire

STRONG FIRST HALF 2024 REVENUE WITH CONTINUING GROWTH MOMENTUM

24 Jul 2024 01:30:00 By Nasdaq GlobeNewswire